Areva Pharmaceuticals Ltd

Areva Pharmaceuticals is a specialist manufacturer dedicated to providing high‑quality oncology injectables and oral solid medicines that go beyond standard generics. By focusing on traditional chemotherapy agents, the company aims to broaden patient access to affordable, effective treatment options while maintaining the highest safety standards.

The firm’s core expertise lies in the production of sterile, highly controlled injectable formulations and a range of oral solid dosage forms. Areva’s state‑of‑the‑art manufacturing facilities are among the most advanced globally, offering meticulously sterile environments and rigorous containment of raw materials and finished products at every stage. This sophisticated infrastructure supports a diverse capacity for vials and ampoules, ensuring that each product is both safe and user‑friendly, thereby minimising the risk of human error during administration.

Through substantial investment in cutting‑edge technology and a commitment to quality, Areva Pharmaceuticals leads the market in delivering affordable, high‑quality generic oncology medicines to healthcare providers and patients worldwide.